The extracellular environment contains a wide assortment of proteoglycans that interact in a complex manner with proteins and peptides resulting in a variety of important biological consequences. Heparan sulfate is one of the most important proteoglycans in the extracellular matrix. Heparin, a related glycosaminoglycan, has been much more extensively studied for the ability to interact with proteins because heparin is a readily available anticoagulant that is a commercial drug. Heparan sulfate and heparin have many similar structural features, and both interact with many extracellular matrix proteins. Experiments over the past 5 years have begun to provide an understanding of the structural requirements for these interactions to occur. Heparin and heparan sulfate binding proteins with specific sites rich in basic residues, often contained in secondary structural domains that bind acidic oligosaccharides with high specificity and affinity. Recent studies suggest that specific sequences also exist within glycosaminoglycans that have high specificity and affinity for binding protein partners. This application is based upon these new observations, and proposes to produce and evaluate """"""""designer"""""""" glycosaminoglycans with increased specificity and affinity for binding to proteins. The first grant period allowed this laboratory to develop a much clearer understanding of the structural requirements for glycosaminoglycans and proteins to interact. In this renewal period, the laboratory will evaluate the hypotheses that 1) glycosaminoglycans from various tissues differ in binding affinities and specificities for proteins and peptides and 2) designer glycosaminoglycans can be produced that have enhanced affinity and specificity for bind partners. The primary aims are to: 1) examine tissue specific differences in heparan sulfate; 2) design and construct protein binding sites in glycosaminoglycans; and 3) perform fundamental structure-activity relationship studies to determine in much more detail, requirements for glycosaminoglycans and proteins to interact by studying thermodynamics, kinetics, precise contact points and other important factors that influence these interactions. The principal glycosaminoglycan target will be heparan sulfate, prepared from selected tissues of normal and knockout mice and modified with 3-O-sulfotransferase isoforms to construct structurally unique binding sites. The secondary aims are to develop high-through-put methods for screening glycosaminoglycan-protein interactions; expand the library of structurally defined oligosaccharides; and evaluate new biophysical methods for studying glycosaminoglycan-protein interactions.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL052622-07
Application #
6537134
Study Section
Pathobiochemistry Study Section (PBC)
Program Officer
Link, Rebecca P
Project Start
1996-02-01
Project End
2005-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
7
Fiscal Year
2002
Total Cost
$257,250
Indirect Cost
Name
University of Iowa
Department
Other Health Professions
Type
Schools of Pharmacy
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Copeland, Ronald; Balasubramaniam, Arun; Tiwari, Vaibhav et al. (2008) Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry 47:5774-83
Garg, Hari G; Mrabat, Hicham; Yu, Lunyin et al. (2008) Significance of the 2-O-sulfo group of L-iduronic acid residues in heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells. Carbohydr Res 343:2406-10
Zhang, Zhenqing; McCallum, Scott A; Xie, Jin et al. (2008) Solution structures of chemoenzymatically synthesized heparin and its precursors. J Am Chem Soc 130:12998-3007
Warda, Mohamad; Zhang, Fuming; Radwan, Moustafa et al. (2008) Is human placenta proteoglycan remodeling involved in pre-eclampsia? Glycoconj J 25:441-50
Murugesan, Saravanababu; Xie, Jin; Linhardt, Robert J (2008) Immobilization of heparin: approaches and applications. Curr Top Med Chem 8:80-100
Bhattacharyya, Sumit; Gill, Ravinder; Chen, Mei Ling et al. (2008) Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J Biol Chem 283:10550-8
Zhang, Zhenqing; Weiwer, Michel; Li, Boyangzi et al. (2008) Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation. J Med Chem 51:5498-501
Guerrini, Marco; Beccati, Daniela; Shriver, Zachary et al. (2008) Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol 26:669-75
Sinnis, Photini; Coppi, Alida; Toida, Toshihiko et al. (2007) Mosquito heparan sulfate and its potential role in malaria infection and transmission. J Biol Chem 282:25376-84
Hrtska, Sybil C Lang; Kemp, Melissa M; Munoz, Eva M et al. (2007) Investigation of the mechanism of binding between internalin B and heparin using surface plasmon resonance. Biochemistry 46:2697-706

Showing the most recent 10 out of 103 publications